About 34 Trademarks found that are owned by Durect Corporation

Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, neurological diseases and disorders, central nervous system diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders

The mark consists of the stylized word "durect" with the letter 'e' having a gradient crossbar and with the letter 'd' in the form of an abstract DNA symbol with gradient effect.

[ Surgical, medical, dental, and veterinary instruments and apparatus, namely, speculum; products and instruments for the delivery of fluids to the ear and for the treatment of ear disorders, namely, ear catheters; ] implantable and non-implantable pumps sold without medication for use in dispensing fluids and medications into [ humans and ] animals; [ measuring devices, diagnostic devices, sizing devices and surgical insertion instruments used in connection with products and instruments for the delivery of fluids to the ear and for the treatment of ear disorders ]

Miniature fluid dispensers for experimental use in laboratory animals; [and in vitro] implantable and non-implantable pumps for use in dispensing fluids and medications into animals for scientific use

implantable and non-implantable pumps for use in dispensing fluids into small animals

pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders

pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders

pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders

Surgical or medical pharmaceutical preparations, namely, injectable and implantable drug delivery formulations used with anesthetic or analgesic medications for controlled or sustained release of the medication; pharmaceutical preparations, namely, depot therapy drug formulations for use with anesthetic or analgesic medications; pharmaceutical drug delivery formulations, namely, drug delivery agents consisting of anesthetic or analgesic compounds for use with a range of pharmaceutical preparations for controlled or sustained release of medication into the body; surgical and medical drug delivery systems consisting primarily of depot devices for the delivery of anesthetic or analgesic drugs

Research and development of pharmaceutical preparations and medical devices; research and development of biodegradable polymers for pharmaceutical and biotechnology companies